Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com.
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season.
The updated mRNA vaccines, Comirnaty and Spikevax, were fully approved for people 12 years and older, while the Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine were granted emergency authorization for children 6 months through 11 years of age, according to an FDA announcement released today. The monovalent (single) vaccines are designed to target the Omicron variant KP.2 strain of SARS-CoV-2.
RISKS ASSOCIATED WITH THE COVID VACCINE IDENTIFIED IN STUDY "These vaccines were updated to provide better protection against COVID-19 caused by circulating variants," the FDA stated. "Vaccination continues to be the cornerstone of COVID-19 prevention ," said Peter Marks, M.D.
, Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, in the FDA announcement.
The U.S. Food and Drug Administration has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season.
(REUTERS/Andrew Kelly/File Photo) "These updated vaccines meet the agency’s rigorous scientific standards for safety, effectiveness and manufacturing quality." CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER "Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consi.